Lv1
36 积分 2022-06-14 加入
Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation
11小时前
已完结
CRISPR-engineered T cells in patients with refractory cancer
16天前
已完结
Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma
20天前
已完结
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
23天前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
1个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7
1个月前
已完结
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells
1个月前
已完结
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies
1个月前
已完结
皖公网安备34019202002308
